Daewon Pharm, established in 1958, specializes in manufacturing prescription drugs (Finished Products). It is especially strong in R&D focusing on NCE and IMD. In 2013, Daewon recorded 160 Million USD of total sales turnover. Daewon is exporting its ETC and OTC products over 30 countries including emerging markets such as China and Russia. Our team is dedicated to supporting our partners in every aspect. Daewon's representative products are as follows: Pelubi Tab (Pelubiprofen, NCE, NSAID Type), Megex-I ES Susp (Megestrol Acetate), Wontran ER Tab. (Acetaminophen + Tramadol), Oramin-F Cap. (Multi-vitamin + Korean Ginseng), and Propofol MCT-LCT Inj.
Since its establishment
in 1945, Daewoong Pharmaceutical has grown to become one of the top 5
pharmaceutical companies in Korea. With its strong and competent in-house
R&D and qualified manufacturing facilities (cGMP), Daewoong provides a
total healthcare solution to patients across the globe. We manufacture various products (ETC&OTC) including Biologic, Chemical, Medical Device, etc.
Products: Finished Dosage Formulations (Biologic & Chemical), APIs, Antibiotics, Enzymes
Interests: In-licencing, Out-licensing, CDMO
7 Manufacturing Sites (3 Overseas, 4 Korea)
6 Billion Units manufactured annually
Exporting to 90 Countries
70 Years of Experience
3 Overseas R&D centers
8 Global Sales Networks (Branch & Corporation)
770+ Employees working in R&D and Manufacturing (CDMO related) area
678 Drug Approvals up to date
With over 80 years of experience in fluorine research and development, Daikin Chemicals is one of the world's leading manufacturers of fluorochemical products today and committed to innovation in the field. Daikin produces and offers a wide range of intermediates and a series of fluorinating agents, e.g. HFA - Solkane propellants for use in inhalation sprays, as well as custom synthesis of a variety of organic compounds. Daikin's commitment has always been to meet customers' existing and future needs along with providing precise technical service tailored to a customer's specific requirements.
Dalchem operates on the world market of fine chemicals since 1997. Dalchem manufactures organophosphorus and organometallic chemicals (binaphthyl and biphenyl phosphine ligands, cyclopentadienyl derivatives) in kilo-lab scale up to 3000 kg/year. Usage of stainless steel reactors with capacity 20 lt (56 pcs), 65 lt (17 pcs) and 100 lt (44 pcs), allow to carry syntheses in temperature interval from -70 to +200°C. Short path distillation plant (VTA) is used for some distilling processes. We're experienced in work with air-, moisture-sensitive and pyrophoric organometallic compounds. 2 GloveBoxes PureLab (Inert Corp.) are used for packaging of air- and moisture sensitive materials. We use Huber Unistats (151W, 520W, 910W) (22 pcs) and Huber Unichillers (UC210Tw-4) (14 pcs) to carry process in a wide temperature interval. Dalchem rents in total about 6000 m2/65000 sq.ft. by the end of 2016. All products pass Multifactorial Quality Control, allowing to reach the highest purity of products.
Danapak Flexibles A/S offers unique innovative flexible packaging solutions to the pharmaceutical and healthcare industries. We have a proven track record for over 30 years, highlighting our vast experiences in packaging and dedication to fulfil our customers' requirements.
Visit us at Stand 42K01 and together we can optimise your future product success.
Darbox has a worldwide reputation for over 50 years of excellence in the design, development, production and supply of innovative packaging. Clients include leading companies in the pharmaceutical, chemical, cosmetics, intermediates, excipients and other ingredients industries. Darbox focuses on eco-friendly, HDPE/PP plastic, open-top, stackable, nestable, heavy-duty and UN-certified packaging containers from 10-120L for the transportation and storage of solid and semi-solid dangerous and high-value goods (APIs, powders, tablets, pastes, capsules). We are ISO 9001:HACCP-certified.
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global health care world. Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our health care offering, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Partnering up with the world's top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure all patient's safety and improve patients' lives.
DavosPharma, a leading provider of discovery, chemistry and formulation services, offers solutions to both emerging biotech and established multinationals during drug development with supporting developmental, analytics, stability and regulatory documentation. DavosPharma has forty years of custom manufacturing experience, forming global strategic alliances with carefully vetted, best-in-class, cGMP custom manufacturers.
DCC Healthcare is a division within DCC plc. DCC Health and Beauty Solutions is a leading contract manufacturer to the global health and beauty markets and offers a breadth of product and innovation to global brand leaders including; softgels, tablets, oral & topical OTCs, medical devices, healthcare creams, premium cosmetics and liquid nutritional products. DCC Vital Pharma develops, manufactures, markets, and distributes a broad range of pharmaceutical products in the UK & Ireland to the hospital and community pharmacy sectors. For our international customer base we provide contract manufacturing services for oral beta-lactams and out-licensing of our own developed products.
Decens Biological Technology Co Ltd specializes in APIs, fine chemical R&D, production and API-marketing. Our major products are 8- Hydrioxyquinolones derivatives and other fine chemical products. Halquinol has acquired property rights. We are certificated by ISO9001: 2008 system. In 2013, we renovated all company equipment and introduced GMP system.
Delpharm is in the top 5 of the European CDMO, committed to delivering high quality products and services since 30 years. Delpharm produces most dosage forms in 12 productions sites located in France, Italy and Belgium. With more than 3200 people working in the company, Delpharm has a turnover of 500 Million Euros. Delpharm devotes annually 30 to 40 Million Euros to investments and innovative solutions.
Delta2000 produces, and installs all over the world, modular walls, doors, suspended ceiling and accessories for cleanrooms, thanks to its experience and innovation. The quality of our products starts with the raw materials purchased from our suppliers, which are carefully selected to achieve results to be proud of.
Demo SA specializes in the research, development, manufacturing and marketing of finished generic pharmaceutical products mainly for hospital use. Demo SA has a wide portfolio of products as injectable antibiotics (cephalosporins, quinolones etc), standard IV solutions of large and small volume (as Sodium Chloride, Dextrose, Ringers Lactate, Water for Injection) antiemetics, sedatives etc. Demo SA is looking for suitable partners in Europe and outside Europe for the distribution and marketing of its products. Demo SA' objectives is the approval and marketing of its hospital products on a paneuropean level.
With 58 establishments and 9300 jobs, the Centre Loire Valley region is one of France's leading regions for the production of medicines. The region's sectoral fabric is made up of big pharmas, foreign laboratories, LFIs (Independent French Laboratories), contractors, research and training centres. Since 2002, with so many major French and international pharmaceutical companies long established within its borders and a high value-added range of know-how and skills to its credit, it has been home to Polepharma, bringing together a wide-reaching network of local SMEs and large specialised groups in a shared-work dynamic.
DEV'UP's objective is to highlight the economic attractiveness of the Centre-Loire valley region. To this end, many activities are carried out all year round - prospecting missions, participation in many promotional events in France and abroad, welcoming potential investors, advertising campaigns, etc.
Deva Holding, established in 1958, is one of the leading pharmaceutical companies in Turkey with EU GMP certified manufacturing facilities, 2000 employees, more than 300 molecules in over 600 different dosage form in Turkish Pharma market and with excellent manufacturing capabilities for nearly all kind of pharmaceutical forms.
Deva develops, produces, markets and sells its high quality finished products, APIs and animal health products worldwide.
Deva offers a wide range of products in antibacterial, antineoplastic, musculoskeletal, cardiovascular, gastrointestinal, respiratory, central nervous system, dermatology and hormones. Deva is constantly seeking to extend its international activities through its partners by license & supply agreements, contract manufacturing, and strategic alliances.
The company's R&D activities are conducted at dedicated laboratories, certified as R&D center in May 2010, with its 150 researchers. Its certified EU-GMP starts with product research and development and covers all processes from production to distribution networks to meet international quality and compliance standards. Deva Holding also has a dedicated and experienced team of specialists in its International Markets Regulatory Affairs Department who contribute to Deva's continuous success by preparing and submitting products dossiers according to country specific regulations.
We are a leading manufacturer of Cephalosporin Antibiotics in India with a capacity of 100MTPA of Cephalosporins, exported worldwide to more than 20 countries. Our Company holds the COFEPRIS issued by MEXICO authority for our flagship product. The company is in the process of filing several other product registrations across China, Japan and Europe. We have several technical tie-ups for technology transfer with major manufacturers across the world. Our strengths lie in custom synthesis, R&D, Scale-up and Commercialization of new products. Our current commercial products are: Cefixime, Cefdinir, Cefaclor, Cefuroxime Axetil, Cefpodoxime Proxetil, Cefditoren Pivoxil, Ceftibuten, Cefprozil, Cefcapene, Ceftamet Pivoxil 7AVCA, 7ACCA, Cefuroxime Acid, Cefpodoxime Acid
Di Renzo Regulatory Affairs is an Italian company providing regulatory consulting services in the field of medicines for human and veterinary use, medical devices, biocides, food supplements and cosmetics. The company has a large staff of technical experts and is based in Rome with a branch office in Milan.
Dipharma is one of the leading European manufacturers of Active Pharmaceutical Ingredients, offering about 50 APIs with DMFs lodged worldwide. All three manufacturing sites have been successfully inspected by the European and US Authorities. A fully-equipped R&D Centre, supported by internal Intellectual Property department, develops innovative processes and crystalline forms. One dedicated pilot plant, one small production plant and suitable scale-up facilities make Dipharma the right partner for Custom Synthesis. Core technologies are: Nitration, Nitroesterfication, Complex Hydrogenations, Azidation, Chiral Synthesis, Organometallic, Grignard and Enzimatic chemistry.
DISCH is a leading player in the European market regarding development and contract manufacturing of pharmaceuticals, medical devices and food supplements based on technologies developed in the confectionery industry.
At DISCH, we have been manufacturing sugar based products for over 100 years and
since 2003 DISCH has focused mainly on pharmaceutical products. The manufacturing of
pharmaceuticals and medical devices now makes up to around 80% of the activities.
With an increasing focus on the growing demands of the pharmaceutical industry, we are
continuously upgrading our technological and organizational structures in order to meet the
high standards of our customer's needs as well as the requirements by the authorities.
As a privately owned company our way of thinking and doing business is oriented towards
the long term. It is our goal to continue developing the company for the benefit of all involved
parties in order to offer the highest possible degree of quality, safety and continuity.
DISPROQUIMA is a group with presence on four continents and a high degree of expertise in distribution, marketing and product development, services and solutions to the world of “LIFE SCIENCES”. We deal with reliable and well known suppliers worldwide with appropriate quality standards which allow us to offer a wide range of products to our customers: APIs duly documented (DMF/COS; GMPs; WC…), excipients for different uses (direct compression, Orodispersable dosage forms, effervescent, etc…), functional ingredients, commodities and additives. The 9000m2 facilities make our central premises able to provide warehouses specific for temperature-controlled products, flammable products and health care products. Besides, Disproquima has at your disposal 11 logistic bases complying with GMP/GDP standards. A dedicated sales team will help you in any of the 11 countries where we are present, offering a deep technical knowledge and extensive expertise in their markets. We welcome you to contact us, we'll be glad to offer you A WORLD OF POSSIBILITIES
Divasa-Farmavic,S.A. is one of the few EU veterinary manufacturers with fully GMP approved facilities to manufacture: >Beta-lactam and non-beta-lactam totally separate production lines for injections/solids: Sterile Solutions, aseptic and terminal sterilization. Sterile Suspensions. Extemporaneous powder for injections. Oral Soluble Powders. Medicated Premixes. >Aerosols >Pets collars >Oral and topic solutions
Limited is a globally recognized pharmaceutical company. Divis has an
overwhelming track record as a dependable supplier of APIs and
custom manufacturer for the big pharma for nearly two decades.
Divi's manufacturing sites had successful audits by USFDA, KFDA, BGV-Hamburg, PMDA-Japan and JAZMP-Slovenia. Unmatched infrastructure: Divis has 4 R&D centres manned by 325 scientists; 2 manufacturing sites with scale up facilities, kilo lab and pilot plants; 32 production buildings with 48 pharma suites; 1055 reactors with total capacity of 7851m3. Certifications: ISO9001; ISO14001; OSHAS18001; FSSC22000. Drug Master Files: USDMF-39; CoS-17; PRMf-24; ASMF-250; KDMF-11; PMDAMF-7
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets. Publicly listed on the SIX Swiss Exchange since 2012, DKSH is a global company headquartered in Zurich. With 825 business locations in 37 countries – 800 of them in Asia – and 31,970 specialized staff, DKSH generated net sales of CHF 11.0 billion in 2017. DKSH was founded in 1865. With strong Swiss heritage, the company has a long tradition of doing business in and with Asia and is deeply rooted in communities and businesses across Asia Pacific. DKSH Business Unit Performance Materials is a leading specialty chemicals distributor and provider of Market Expansion Services for performance materials, covering Europe, North America and the whole of Asia. The Business Unit sources, develops, markets and distributes a wide range of specialty chemicals and ingredients for pharmaceutical, personal care, food & beverage as well as various industrial applications. In addition, it creates innovative and cutting-edge concepts and applications in 29 innovation centers located worldwide. With 100 business locations in 31 countries and around 1,010 specialized staff, Business Unit Performance Materials generated net sales of CHF 894.1 million in 2017.
DFE Pharma is an international company that specializes both in manufacturing world-class excipients and in partnering with leading pharmaceutical companies to improve their own product performance. DFE Pharma is jointly owned by two of the world's top multi-national dairy companies: Royal FrieslandCampina and Fonterra, and has production locations in the Netherlands, Germany, New Zealand and India.
DMV-Fonterra Excipients launches Dual-Sourcing Quality, Reliability, Expertise - are DMV-Fonterra Excipient's three core pillars and our commitment to our customers. This year DFE has taken reliability one step further to demonstrate our commitment and enhance the security of supply. DFE is one of the first excipient suppliers in the world that offers Dual-Sourcing, and the only one to offer this for Pharmaceutical grade lactose. Dual-Sourcing is a unique service, enabling you to benefit from our manufacturing sites located in different continents. Please come and meet us to hear about DFE's launch of Dual-Sourcing in hall 3. 1, booth 31-B03.
DNS Fine Chemicals is engaged in manufacturing and export of fine chemicals for a variety of industrial requirements. With roots that go as far back as 10 years, it has grown into a highly- matured and experienced company. These industrial chemicals are used in a number of applications in pharmaceutical sector, agricultural sector, food and beverages sector, paper, textiles etc.
We are REACH registered for some of our products. We are also approaching for US FDA WHO. For more information about our products, please visit our website: www.dnsexportsindia.com and www.iodinederivatives.com.
Doctor Pack is a trusted Packaging and Device partner to leading global healthcare, pharmaceutical, diagnostics companies, hospitals, retail pharmacies and contract packagers.
We specialize in design, develop and manufacture of primary packaging, drug delivery system, medical devices, customised plastics components. The special emphasis is given to enhanced patient friendly and child safety. Besides other benefits our innovations focus on making the products affordable in healthcare dispensing systems, Medical Devices, Primary packaging, diagnostic devices such as Lancing Devices, Need safe system, vials and closures for over-the-counter and prescription drugs.
We drive innovation and product performance for the pharmaceutical industry with advanced drug delivery systems for applications including:
Ophthalmic Delivery System
Parenteral Delivery Devices
Nasal Delivery System
Inhalation Delivery System
Oral Delivery System
Diabetes Delivery Devices
Doctor Pack is more than just a packaging company. We provide comprehensive support to your product's lifecycle from innovation through commercialization via patient-centered delivery solutions.
To strengthen and grow our Leadership Position in Pharma and Health Care Packaging by providing Prompt, Innovative, Cost Effective and Aesthetically Superior Packaging, Drug Delivery System, Medical Devices, developed and manufactured in compliance with cGMP standards.
We exist to create Benefit and Value to our Internal & External Customers.
Continue to be the pioneer in introducing Innovative Products, adopting the Latest Technology, Materials, cGMP and the Global Standards.
In next 5 years we want to be one of the top 10 global Pharma packaging and Drug Delivery System Company with plants around the Globe.
We want to be the Globally Preferred “Perfect Packaging & Innovative Device Partner” who provides innovative, cost effective Solutions.
We are committed to “The Total Customer Satisfaction” by:
Delivering the best to our customers in terms of products, services and economics by strictly adhering to the international standards and systems being adopted by us.
Implementing and sustaining current Good Manufacturing Practices at all level.
Striving for continual improvement in the respective areas of innovation, product quality Production processes, Training, On Time Delivery, Waste reduction etc.
Environment Management System
We are fully committed to prevent all forms of Pollution and provide Safe and Healthy Environment to all our Business partners including Customers, Suppliers, Employees, Society, and Government Body etc.
Our EMS Policy is to:
Fully comply with the requirements of current environmental legislation and EMS.
Minimize our waste by ensuring the most efficient operation.
Minimize Energy and Water usage by adopting the latest Energy Efficient Technology.
Apply the principles of continuous improvement with respect to air, water and noise pollution from our operations.
Ensure that all employees understand, adhere and contribute to our environmental policy by motivation and providing regular training.
Promote Green Revolution by planting more Trees and aim for paper free office.
Domaco Dr. med. Aufdermaur AG, Switzerland. Domaco pharma is a new division within the Domaco Group. Specialised for high quality products with active pharmaceutical ingredients and therapeutic plants. Full service: research and development, consultancy and conception, manufacturing, packaging, project management, compiling dossiers for pharmaceutical projects. Quality standards: ISO 9001:2008, BRC grade A, IFS higher Level, GMP Swissmedics, organic. Technologies: instantizing, moulding, pressing, casting. Dr. med. Aufdermaur AG, Pharmaceutical Division, Weststrasse 16, CH-5426 Lengnau, Switzerland. Phone: +41 56 266 5521. Contact: [email protected] Visit www.domaco-pharma.com.
Dong-A has been the largest pharmaceutical company in Korea since 1967. We have solidified our leading market position on the strength of in-house developed products such as Suganon tab. Evogliptin, the DPP-4 inhibitor for type 2 diabetes mellitus, Zydena tab. Udenafil, the fourth PDE5 inhibitor in the world for erectile dysfunction, Stillen tab. Eupatilin for herbal treatment of gastritis and Motilitone tab. Corydaline for functional dyspepsia. Furthermore, we are offering branded generic drugs (anti-cancer, anti-TB, etc.), bio-pharmaceutical, IMD, APIs and OTC products ensuring full compliance to international quality standard. Currently Dong-A is exporting its products to more than 50 countries to leading pharmaceutical companies in Europe, Latin America and Asia.
Dongkook Pharmaceutical was founded in 1968 and since its foundation, Dongkook has concentrated on R&D and technology innovation. Dongkook is well known for OTC products of high brand values in Korea. Additionally, Dongkook has developed and produced outstanding therapeutic products including anesthetics, contrast media and anti-cancer agents. Dongkook has been recognized by domestic and foreign authorities for its quality of finished products, medical devices and APIs. Currently, Dongkook exports the finished products, medical devices and APIs to over 50 countries around the world, and seeks to grow into a global leading pharmaceutical company.
Novolite Chemicals Co Ltd is a high tech enterprise that was established by a group of reputable professors and doctors in 2002. Our aim is to have our update research come into the real industrial scale production to support our customer's drug development program. We established our technical research and develop base on Shanghai China East University of Science and Engineering, and established our producing facility in Wujiang and Zhangjiagang, Jiangshu, which is built under GMP requirement of Pharmaceutical industry. Every day, every dedicated employee in Novolite is focused to satisfy our customers. Biochemistry, chemistry, and their related technologies form our core competencies and it is our pleasure to introduce these to you.
is a contract development and manufacturing organization (CDMO). Headquartered
in Italy with two state-of-the-art finished dosage
forms manufacturing sites, the Company offers a full range of
manufacturing and packaging services for its national and
Through its highly advanced R&D labs and pilot scale facilities, Doppel can provide with customized product and process development (which range from pre-formulation to industrial scale production), including manufacturing of IMP batches, regulatory support and CTD drafting services.
Dott. Bonapace & C is a worldwide and well-known Italian manufacturer of lab-scale equipment for pharmaceutical R&D departments, nutraceutical laboratories, etc. In our equipment range, you can find semi-automatic and fully automatic capsule filling machines, rotary and single punch tablet presses, suppository lines, blistering machines, powder and liquid dosers, etc. Special WIP and isolated applications are also available.
Douglas Pharmaceuticals has operations
in New Zealand, Fiji and the USA and representatives in Germany and the USA. Douglas has expertise in high potency
products (retinoids, anticancer, steroids, vitamin D) as soft gel capsules,
semisolids, capsules and tablets. The
company complies with EU and US GMP and was successfully inspected by the FDA
in 2007, 2011 and 2015. A number of
ANDAs and NDAs are under review, with a number of products launched in the
USA. New Zealand and the EU have a
Mutual Recognition Agreement on GMP, facilitating product supply into
Europe. Douglas exports to more than 60
customers, including pharmaceutical companies in Europe, North America, Canada,
Asia, Middle East and Australia. A key cornerstone of our business
includes contract manufacturing and analytical services for several
multinationals as well as small generic pharmaceutical companies.
DPT, a Mylan company, is a leading contract development and manufacturing organization, recognized for its excellence in semi-solid and liquid dosage forms. Founded in 1938, DPT provides the best development and manufacturing solutions for our customers. Backed by a team of approximately 1,000 employees in San Antonio, Texas, DPT has unmatched experience, resources and capacity to efficiently serve your pharmaceutical development and manufacturing needs –no matter the scope.
From concept to commercialization, DPT remains committed to exceeding expectations for quality and service. No other company offers a 75-plus year history of stability, superior technical expertise and regulatory merit in semi-solids and liquids.
Dr Müller Pharma offers contract production of pharmaceuticals, medical devices, food supplements and cosmetics (non-sterile semi-solid products, suppositories, hard boiled lozenges, batch release and certification, primary and secondary packaging of tablets, capsules, quality control testing, batch release and certification of imported medicinal products. Family company established 1995.
Paul Lohmann® is the world's leading manufacturer of high-purity
mineral salts for the pharmaceutical, nutritional supplement, food and personal
care industries. More than 130 years of manufacturing experience - combined
with innovation and flexibility - enables Dr. Paul Lohmann® to
respond rapidly to your changing needs. Dr. Paul Lohmann® provides
customers with the broadest available portfolio of mineral salts, with more
than 400 products and over 7,000 qualities, designed to provide optimum
performance across a wide range of applications.
Custom-made mineral salts
As well as offering standard products at quality levels stipulated by pharmacopoeias, Dr. Paul Lohmann® develops and optimizes products and product grades according to the customer's requirements. This optimization includes the adaptation of chemical and physical parameters such as bulk density, wettability, particle size, purity and pH-value. These parameters can be adjusted to a very fine level for almost all mineral salts. Our experienced R&D department works in close cooperation with our customers to fulfil their specific needs.
Low-endotoxin mineral salts
The low-endotoxin products are manufactured in a purpose-built facility. Low-endotoxin mineral compounds can be used for solutions for infusions, injections, preparations for dialysis and for biopharmaceuticals.
Mineral salts – from pilot plant scale to industrial production
As API manufacturer, Dr. Paul Lohmann® offers complete pharma documentation, such as DMFs, ASMFs and CEPs for submission to various health authorities worldwide.
The production sites are GMP, FSSC 22000/ISO 22000 and ISO 9001:2015 certified. The production site Emmerthal is successfully inspected by FDA (U.S. Food and Drug Administration) in the context of FSMA (food safety modernization act). Also the social and environmental standards are DIN EN ISO 50001 and Sedex certified.
As a global player Dr. Paul Lohmann® has sales subsidiaries in Singapore, New York/USA, Eindhoven/The Netherlands and Evry/France.
Dr. Pfleger Arzneimittel GmbH is a midsized pharmaceutical company in Bamberg, Germany. It was established in 1945 and is owned by the Doktor-Robert-Pfleger-Foundation which supports medical research and charitable and social causes. We provide a full range of services for the development, manufacture, analysis, storage and distribution of pharmaceuticals, dietary supplements and cosmetics. Drawing on our over 70 years of experience, we supply products to more than 40 countries worldwide. We cordially invite you to visit us at our stand 120C60.
With more than 30 years of experience and a strong technical foundation, we supply products and services to customers in Latin America, Middle East, Asia, and Africa. Our business areas include: Active Pharmaceutical Ingredients, Business Development, Pharmaceutical Product Dossiers, Product Development Services, Business and Technical Consulting and Contract Manufacturing Operations. With DROMEX INTERNATIONAL as your partner, you can trust to access a single source solution with expertise that fits your unique needs for both pharmaceuticals and biopharmaceuticals.
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences, DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 23,500 employees deliver annual net sales of around €9 billion. More information can be found at www.dsm.com.